Bath & Body Works, Inc.BBWI
Bath & Body Works, Inc. Debt Disclosure
Long-term Debt and Borrowing Facility
The following table provides the Company’s outstanding Long-term Debt balance, net of unamortized debt issuance costs and discounts, as of February 3, 2024 and January 28, 2023:
| February 3, 2024 | January 28, 2023 | ||||||||||
| (in millions) | |||||||||||
| Senior Debt with Subsidiary Guarantee | |||||||||||
$314 million, 9.375% Fixed Interest Rate Notes due July 2025 (“2025 Notes”) | $ | 313 | $ | 317 | |||||||
$297 million, 6.694% Fixed Interest Rate Notes due January 2027 (“2027 Notes”) | 287 | 283 | |||||||||
$462 million, 5.250% Fixed Interest Rate Notes due February 2028 (“2028 Notes”) | 460 | 498 | |||||||||
$500 million, 7.500% Fixed Interest Rate Notes due June 2029 (“2029 Notes”) | 492 | 491 | |||||||||
$938 million, 6.625% Fixed Interest Rate Notes due October 2030 (“2030 Notes”) | 930 | 991 | |||||||||
$811 million, 6.875% Fixed Interest Rate Notes due November 2035 (“2035 Notes”) | 806 | 993 | |||||||||
$613 million, 6.750% Fixed Interest Rate Notes due July 2036 (“2036 Notes”) | 608 | 694 | |||||||||
| Total Senior Debt with Subsidiary Guarantee | 3,896 | 4,267 | |||||||||
| Senior Debt | |||||||||||
$294 million, 6.950% Fixed Interest Rate Debentures due March 2033 (“2033 Notes”) | 293 | 349 | |||||||||
$201 million, 7.600% Fixed Interest Rate Notes due July 2037 (“2037 Notes”) | 199 | 246 | |||||||||
| Total Senior Debt | 492 | 595 | |||||||||
| Total Long-term Debt | $ | 4,388 | $ | 4,862 | |||||||
The following table provides principal payments due on outstanding Long-term Debt in the next five fiscal years and the remaining years thereafter:
| Fiscal Year | (in millions) | |||||||
| 2024 | $ | — | ||||||
| 2025 | 314 | |||||||
| 2026 | 297 | |||||||
| 2027 | — | |||||||
| 2028 | 462 | |||||||
| Thereafter | 3,357 | |||||||
Cash paid for interest was $346 million in 2023, $339 million in 2022 and $354 million in 2021.
Repurchases of Notes
The gains and losses on the extinguishment of debt include the write-offs of unamortized issuance costs and are included in Other Income (Loss) in the Consolidated Statements of Income.
2021 Repurchases
In April 2021, the Company redeemed the remaining $285 million of its outstanding 5.625% senior notes due February 2022 and $750 million of its outstanding 6.875% senior secured notes due July 2025. The Company recognized a pre-tax loss related to this extinguishment of debt of $105 million (after-tax loss of $80 million).
In September 2021, the Company completed the tender offers to purchase $270 million of its outstanding 5.625% senior notes due October 2023 (the “2023 Notes”) and $180 million of its outstanding 2025 Notes for an aggregate purchase price of $532 million. Additionally, in October 2021, the Company redeemed the remaining $50 million of its outstanding 2023 Notes for an aggregate purchase price of $54 million. The Company recognized a pre-tax loss related to this extinguishment of debt of $89 million (after-tax loss of $68 million).
2023 Repurchases
During 2023, the Company repurchased in the open market and extinguished $485 million principal amount of the Company’s outstanding senior notes. The aggregate repurchase price for these notes was $447 million, resulting in pre-tax gains of $34 million, net of the write-off of unamortized issuance costs, during 2023.
The following table provides details of the outstanding principal amount of senior notes repurchased and extinguished during 2023:
| (in millions) | |||||
| 2025 Notes | $ | 6 | |||
| 2028 Notes | 38 | ||||
| 2030 Notes | 62 | ||||
| 2033 Notes | 56 | ||||
| 2035 Notes | 189 | ||||
| 2036 Notes | 87 | ||||
| 2037 Notes | 47 | ||||
| Total | $ | 485 | |||
Subsequent to February 3, 2024 through March 22, 2024, the Company repurchased in the open market and extinguished $45 million principal amount of the Company’s outstanding senior notes for an aggregate repurchase price of $45 million.
Asset-backed Revolving Credit Facility
The Company and certain of the Company’s 100% owned subsidiaries guarantee and pledge collateral to secure an asset-backed revolving credit facility (“ABL Facility”). The ABL Facility, which allows borrowings and letters of credit in U.S. dollars or Canadian dollars, has aggregate commitments of $750 million and an expiration date in August 2026.
In the second quarter of 2023, the Company amended its ABL Facility to replace the London Interbank Offer Rate-based rate with a Secured Overnight Financing Rate (“SOFR”) based rate as the interest rate benchmark on U.S. dollar borrowings. This amendment made no other material changes to the terms of the ABL Facility.
Availability under the ABL Facility is the lesser of (i) the borrowing base, determined primarily based on the Company’s eligible U.S. and Canadian credit card receivables, accounts receivable, inventory and eligible real property, or (ii) the aggregate commitment. If at any time the outstanding amount under the ABL Facility exceeds the lesser of (i) the borrowing base and (ii) the aggregate commitment, the Company is required to repay the outstanding amounts under the ABL Facility to the extent of such excess. As of February 3, 2024, the Company’s borrowing base was $539 million and it had no borrowings outstanding under the ABL Facility.
The ABL Facility supports the Company’s letter of credit program. The Company had $10 million of outstanding letters of credit as of February 3, 2024 that reduced its availability under the ABL Facility. As of February 3, 2024, the Company’s availability under the ABL Facility was $529 million.
As of February 3, 2024, the ABL Facility fees related to committed and unutilized amounts were 0.30% per annum, and the fees related to outstanding letters of credit were 1.25% per annum. In addition, the interest rate on outstanding U.S. dollar borrowings was the Term SOFR plus 1.25% per annum and a credit spread adjustment of 0.10% per annum. The interest rate on outstanding Canadian dollar-denominated borrowings was the Canadian Dollar Offered Rate plus 1.25% per annum.
The ABL Facility requires the Company to maintain a fixed charge coverage ratio of not less than 1.00 to 1.00 during an event of default or any period commencing on any day when specified excess availability is less than the greater of (i) $70 million or (ii) 10% of the maximum borrowing amount. As of February 3, 2024, the Company was not required to maintain this ratio.
Free Sentinel
Track for freeWant the next Bath & Body Works, Inc. debt disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Bath & Body Works, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2024 | Mar 22, 2024 | Showing above |
| 2023 | Mar 17, 2023 | |
| 2022 | Mar 18, 2022 | |
| 2021 | Mar 19, 2021 | |
| 2020 | Mar 30, 2020 | |
| 2019 | Mar 22, 2019 | |
| 2018 | Mar 23, 2018 | |
| 2017 | Mar 17, 2017 | |
| 2016 | Mar 18, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.